Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ALDOLASE”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 415 records · Page 23Linked to original sources

Inactive enzyme molecules in aging mice: liver aldolase.

Evidence is presented that there is a considerable accumulation of inactive fructose-1,6-diphosphate aldolase (EC 4.1.2.7) in the liver of senescent mice. Liver aldolase was purified from 3-month-old mice and used to immunize rabbits. It was demonstrated with the monospecific antibody thus produced that the liver aldolase of young adult (3 month) and aged (31 month) mice are antigenically identical. With the antibody, inactive enzyme molecules (crossreacting material) in liver homogenate of old mice were detected. The liver aldolase of senescent mice had half as much active enzyme per mg of protein, as well as per antigenic unit, as did the liver aldolase of young adult mice. The accumulation of faulty enzyme molecules may be one of the causes of debilitation leading to senescence and death.

Aging↗

Characterization of the inactive form of fructose-1,6-bisphosphate aldolase isolated from livers of fasted rabbits.

The accumulation of an inactive, immunologically crossreactive form of fructose-1,6-bisphosphate aldolase (EC 3.1.3.11) in livers of fasted rabbits has now been related to limited proteolysis at the COOH terminus. The extent of modification of this region of the molecule, determined by analysis of tyrosine residues in the peptides released by digestion with subtilisin, agrees with the observed decrease in the specific activity of the enzyme purified from livers of fasted rabbits. The following evidence supports the conclusion that the modified form is produced in vivo and not during the isolation of the enzyme from the liver homogenates: (i) liver homogenates prepared in isotonic sucrose contained negligible amounts of soluble lysosomal proteinases; (ii) the decreased aldolase activity after fasting was observed in the homogenates and no change in aldolase activity occurred when the homogenates were incubated for 2 hr at 37 degrees C; (iii) the modified enzyme was also isolated from the livers of fasted rabbits when leupeptin was injected intraportally before the animals were sacrificed or when the inhibitor was added to the homogenization solution. On the other hand, homogenization of livers in hypotonic medium resulted in release of lysosomal proteinases and also in decreases in catalytic activity and COOH-terminal modification of liver aldolase, similar to those observed in livers from fasted rabbits. We attribute the changes in activity and structure of aldolase isolated from livers of fasted rabbits to the action in vivo of cathepsin M.

Animals↗

Disruption of the aldolase A tetramer into catalytically active monomers.

The fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) homotetramer has been destabilized by site-directed mutagenesis at the two different subunit interfaces. A double mutant aldolase, Q125D/E224A, sediments as two distinct species, characteristic of a slow equilibrium, with velocities expected for the monomer and tetramer. The aldolase monomer is shown to be catalytically active following isolation from sucrose density gradients. The isolated aldolase monomer had 72% of the specific activity of the wild-type enzyme and a slightly lower Michaelis constant, clearly indicating that the quaternary structure is not required for catalysis. Cross-linking of the isolated monomer confirmed that it does not rapidly reequilibrate with the tetramer following isolation. There was a substantial difference between the tetramer and monomer in their inactivation by urea. The stability toward both urea and thermal inactivation of these oligomeric variants suggests a role for the quaternary structure in maintaining the stability of aldolase, which may be an important role of quaternary structure in many proteins.

Amino Acid Sequence↗

In vivo functional characterization of the aldolase B gene enhancer.

A 400-bp intronic enhancer fragment in conjunction with the proximal promoter of the aldolase B gene provided correct tissue-specific expression in transgenic mice together with hormonal regulation in the liver. We investigated in vivo and in cultured cells the contribution of the intronic regulatory sequences and their interaction with the promoter elements in controlling aldolase B gene expression. Transgene activity was completely abolished by disruption of the two hepatocyte nuclear factor 1 (HNF1) binding sites in the enhancer, whereas mutation of one HNF1 site had no effect in the liver but strongly decreased activity in the kidney. Our data show that the HNF1 binding site(s) in the enhancer were key regulators of aldolase B transgene expression both in the liver and kidney. Deletion of the CCAAT/enhancer-binding protein site in the promoter completely abolished the enhancer function in HepG2 cells. These results suggest that expression of the aldolase B gene in the liver requires cooperative interactions between CCAAT/enhancer-binding protein and HNF1. Deletion of the HNF4 binding site in the enhancer suppressed expression in both liver and kidney in half of the transgenic lines, suggesting that this element might play a role in chromatin opening at the insertion site. We firmly establish that the endogenous aldolase B gene's first response to glucagon or cyclic AMP exposure was a transient increase in the expression in the liver, followed by a secondary decline in the transcription, as previously reported. This response was reproduced by all transgenes studied, indicating that neither HNF1 nor HNF4 binding sites in the enhancer were involved in this biphasic cyclic AMP response.

Animals↗

Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter.

The aldolase B proximal promoter is controlled by at least five elements spanning from -190 to -103 bp with respect to the start site of transcription. From 5' to 3', we found: a negative DE element, an activating C/EBP-DBP binding site, a CCAAT box binding NFY that seems to play a negative role, and an activating element consisting of two overlapping binding sites for HNF-1 and HNF-3. Contransfection experiments of aldolase B/CAT constructs and of expression vectors for different transcription factors were carried out in human hepatoma Hep G2 cells. We found that DBP and HNF-1 are strong transactivators of the aldolase B promoter while C/EBP and vHNF-1 are only weak activators and HNF-3 alone does not modify such activity. Deletion of the distal negative element results in a similar transactivation by C/EBP and DBP, enhanced for the former and reduced for the latter. In hepatocytes in primary culture, the strong transactivator is C/EBP while DBP is essentially inactive. This tissue-specificity of C/EBP and DBP action could depend on interaction with tissue-specific proteins bound to a neighbouring site, probably DE. Finally, HNF3 behaves as a very strong anti-activator of the aldolase B promoter. It competitively antagonizes transactivation by HNF-1 and non-competitively transactivation by DBP. This negative effect of HNF-3 and tissue-specificity of the transactivation potential of DBP and C/EBP are unique features of the aldolase B promoter.

Animals↗

A reactive, surface cysteine residue of the class-II fructose-1,6-bisphosphate aldolase of Escherichia coli revealed by electrospray ionisation mass spectrometry.

The state of post-translational modification of the class-II fructose-1,6-bisphosphate aldolase (FBP-aldolase) purified from Escherichia coli was examined by electrospray ionisation mass spectrometry (ESI-MS). The mass was larger than that expected from the known DNA sequence by approximately 80 +/- 6 Da, suggesting the presence of a covalent modification on the protein. Phosphorylation (+ 80 Da), a known modification in an FBP-aldolase from Bacillus subtilis and a suspected modification in this E. coli aldolase, was ruled out as the extra mass was readily removed by treatment with dithiothreitol. Purification of aldolase by a protocol which omitted 2-mercaptoethanol from all buffers resulted in the purified protein having the expected mass (39016 Da). The extra mass was therefore established as a covalent adduct of the protein with 2-mercaptoethanol (+ 76 Da). Reduction and alkylation studies, followed by isolation of tryptic peptides, established that the site of attachment was Cys36. Although no significant effect of the modification on the activity of the protein was observed, the study underlines the ease with which a protein can be modified covalently by a simple and mild purification procedure; such labelling, which may not always be benign, would be undetectable without the routine use of mass spectrometric analysis.

Amino Acid Sequence↗

Aldolase reaction with sugar diphosphates.

Xylulose-, fructose-, and octulose-diphosphates are substrates for rabbit muscle aldolase with essentially identical K(m) values, but they are cleaved at different rates. After treatment with carboxypeptidase, chymotrypsin, or subtilisin, aldolase cleaves all of these substrates at the same (deceased) rate; the modified aldolase preparations are also equally impaired in their ability to catalyze the detritiation of specifically labeled dihydroxyacetone phosphate. These results suggest that aldolase exhibits "induced fit," in which the rate of cleavage is determined by the distance between the sites on the protein to which the two phosphate groups of a substrate are bound. The activity of the modified aldolases is limited by a step involving making or breaking a carbon-hydrogen bond.

Animals↗

Primary structure and phylogeny of the Calvin cycle enzymes transketolase and fructosebisphosphate aldolase of Xanthobacter flavus.

Xanthobacter flavus, a gram-negative facultatively autotrophic bacterium, employs the Calvin cycle for the fixation of carbon dioxide. Cells grown under autotrophic growth conditions possess an Fe(2+)-dependent fructosebisphosphate (FBP) aldolase (class II) in addition to a class I FBP aldolase. By nucleotide sequencing and heterologous expression in Escherichia coli, genes encoding transketolase (EC 2.2.1.1.; CbbT) and class II FBP aldolase (EC 4.1.2.13; CbbA) were identified. A partial open reading frame encoding a protein similar to pentose-5-phosphate 3-epimerase was identified downstream from cbbA. A phylogenetic tree of transketolase proteins displays a conventional branching order. However, the class II FBP aldolase protein from X. flavus is only distantly related to that of E. coli. The autotrophic FBP aldolase proteins from X. flavus, Alcaligenes eutrophus, and Rhodobacter sphaeroides form a tight cluster, with the proteins from gram-positive bacteria as the closest relatives.

Amino Acid Sequence↗

Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63.

OBJECTIVE: To identify rheumatoid arthritis (RA) specific autoantibody and its antigen in the human osteoblast-like cell line, MG-63. METHODS: MG-63 cell extract was subjected to western blotting by using RA and normal serum samples as probes. The autoantigen was purified and its N-terminal sequence was determined by automated Edman degradation. The reactivity of denatured aldolase A was evaluated by immunoblotting. Screening by enzyme linked immunosorbent assay (ELISA) using the autoantibody was performed. RESULTS: 40 kDa protein was found only in the RA serum samples and it was identified as aldolase A. A polyclonal antibody for rabbit muscle aldolase A bound to the 40 kDa protein and reacted in preference with the denatured enzyme. Using ELISA for denatured rabbit aldolase A, the autoantibody was found in approximately 10% of RA patients, whereas it was not found in the other arthropathy and healthy adults. CONCLUSION: This 40 kDa anti-aldolase A autoantibody, which was identified only in serum samples of RA patients with severe bone erosion, could be related to a certain event that induces RA specific joint destructions.

Adult↗

Human brain aldolase C4 isoenzyme: purification, radioimmunoassay, and distribution in human tissues.

The nervous system specific isoenzyme of frustose-1, 6-diphosphate aldolase (E.C.4.1.2.13), aldolase C4, has been purified from human brain, and a sensitive radioimmunoassay has been developed for its detection. This assay is also capable of detecting other hybrid isoenzymes containing the C subunit but not the A4 isoenzyme. A systematic survey of human organs has shown that immunoreactive aldolase C is present in all human organs but at levels less than 2% of those found in human brain; especially low levels occur in kidney, skeletal muscle, lung, and thyroid tissue. The presence of aldolase C in other organs apart from nervous tissue is unlikely to be explicable by innervation alone since significant quantities are found in erythrocytes. The high degrees of localisation of aldolase C4 in nervous tissue makes it a suitable marker for cell damage within the central nervous system.

Brain↗

[Synthesis of carbohydrate related compounds by using aldolase catalyzed reaction].

Enzymes proceed the reaction with high regio- and stereoselectivity under mild conditions, i.e. in an aqueous medium at room temperature. However, enzymatic reactions that catalyze carbon-carbon bond formation have not been utilized in organic synthesis until recently. We had an interest in an aldolase-catalyzed reaction which proceed carbon-carbon bond formation referred to aldol condensation, by which many bioactive compounds have been rationally synthesized. On the other hand, recent biological studies on cell recognition (cell adhesion) have disclosed the important roles of oligosaccharides on cell surfaces, especially which include glucuronic acid, 3-deoxy-D-manno-oct-2-ulosonic acid (KDO), and sialic acid in the structures e.g., sialyl Lewis X and endotoxins, in differentiation, induction, viral and bacterial infections, and immune response. As well as acidic oligosaccharides, basic ones have been utilized as practical medicines in the clinical level, like acarbose that acts as an amylase inhibitor. Based on these background, we embarked the synthesis of carbohydrate related compounds which can control the interaction between carbohydrates and carbohydrate recognition protein by the use of several aldolases. Azasugars, potent inhibitors toward glycosidases, were synthesized using fructose-1,6-diphosphate (FDP)-aldolase and other dihdroxyacetonephosphate (DHAP)-dependent aldolases in the key step. Sialyl Lewis X mimetic, peptidic mimetic of RNA having anti-Vero toxin activity, mycestericin D, and aza-idulonic acid were prepared by taking advantage of L-threonine aldolase catalyzed reaction, which afford beta-hydroxy-alpha-L-amino acids. A precursor of KDO, featured acidic sugar of endotoxins was provided by the reaction catalyzed with kynureninase, which generates beta-anion of L-alanine in its active site during the metabolic reaction from kynurenine to anthranilic acid.

Carbohydrates↗

[Content of the nonsaponifying substances in crystalline fructosediphosphate aldolase from the muscles of rabbits normally and in atherosclerosis].

The non-saponifying fraction was found in highly purified crystalline preparations of fructose diphosphate aldolase (EC 4.1.2.13). The amount of the non-saponifying substance in the aldolase of intact animals is different and depends not only on the degree of the enzyme purification. In the experiments when the non-saponifying residue was added to the incubation mixture it was found to produce no effect on the aldolase activity with the presence of fructose-1,6-diphosphate and fructose-1-phosphate. A decrease is observed in the activity of the crystalline preparations during their storage for four months which depends directly on the amount of the non-saponifying fraction in these preparations. The amount of the non-saponifying fraction in equally purified preparations of aldolase with experimental atherosclerosis is twice as low as compared to the norm. The non-saponifying residues of the fructose-diphosphate aldolase muscular preparations in the norm and with experimental atherosclerosis consist of two components, one of them being cholesterol, the chemical nature of the other component is not the same in the norm and with atherosclerosis.

Animals↗

[Time of the action of genes controlling the activity of aldolase in embryonal development of groudling].

The time of action of the genes controlling the decrease of aldolase activity (21-23 hrs of development) and its subsequent increase (23-36 hrs) was determined by means of inactivation of the nuclei by actinomycin or heavy doses of irradiation at succesive developmental stages. There exist two distinct periods of gene activity; the former (15-18 hrs) determines the rapid fall of maternal aldolase activity and the latter (21-27 hrs) its subsequent replacement by embryonic aldolase. This result is confirmed by the data concerning the changes in aldolase heat resistance in the hybrids of the loach and tropical cyprinids. The genes controlling the synthesis of the new aldolase and the morphogenesis which takes place at the same developmental stages are functioning at different times, i.e. the biochemical and morphological differentiations may occur relatively independently.

Animals↗

[Localization of aldolase activity in the embryos of loach].

The activity of aldolase was determined in different parts of the loach (Misgurnus fossilis L.) embryo at the stages from the formation of axial organs till the beginning of embryonic movements (from 19 till 38 hrs of development at 21.5 degrees). In all parts of the embryo, the activity of aldolase at first decreased (21-23 hrs) and then increased. The region of somites is characterized by the highest absolute and specific activity at all developmental stages. The increase in the number of somites is accompanied by the fall and subsequent rise of aldolase activity. In the somites of different degree of differentiation, the enzyme activity changes in a similar way. Hence, there is no correlation between the morphological and biochemical differentiation of somites. Differences in the specific aldolase activity between the anterior and posterior halves of the embryo and the regions of head, somites and tail were found at the stages of 19-23 hrs of development. The maternal aldolase only is present at these stages, as was shown earlier. It means that the early stages of biochemical differentiation may be realized not by means of differential activation of genes controlling the enzyme, but by means of regylation of translation on the templates stored in oogenesis.

Age Factors↗

Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis.

BACKGROUND: Chronic liver diseases can progress to cirrhosis and to hepatocellular carcinoma. Timely and unequivocal recognition of the neoplastic evolution of cirrhosis is critical. To this aim, we used a noncompetitive reverse transcription-PCR procedure to analyze aldolase A mRNA in liver tissue from patients with chronic liver diseases at different stages. METHODS: We studied 12 patients with hepatocellular carcinoma, 19 patients affected by chronic hepatitis C or cirrhosis, and 7 healthy controls. Aldolase A mRNA was reverse-transcribed to cDNA, which was then amplified by PCR. The amplified segments were "read" with a novel dot-blot procedure. A calibrator with the same sequence, synthesized in vitro using a T7 phage promoter, was processed at scalar dilutions in parallel to the target samples to generate a calibration curve and so quantify the target mRNA (detection limit, 0.03 amol; linearity spanning five orders of magnitude). RESULTS: Aldolase A mRNA was approximately 10-fold higher in liver biopsies from patients with hepatocellular carcinoma vs patients with chronic hepatitis C or cirrhosis, and healthy individuals. Furthermore, aldolase A mRNA concentrations were 1.2- to 21.3-fold higher in 12 liver biopsies compared with the paired surrounding cirrhotic tissue. CONCLUSIONS: The quantitative analysis of liver tissue aldolase A mRNA differentiates between nonneoplastic chronic liver diseases and hepatocellular carcinoma, which suggests that it has diagnostic potential.

Carcinoma, Hepatocellular↗

Expression of aldolase-controlling genes in hybrid fish embryos. Use of thermostability as a genetic marker.

A new method based on differences in protein thermostability has been proposed for studying genetic control of protein synthesis during development. The effectiveness of this method was checked for aldolase, whose thermostability was established from the temperature required for 50% inactivation after heating for 30 min (T50%). Eggs from a relatively cryophilic species, the loach, were fertilized with sperm from warm-water aquarium fish: the danio, barb, rasbora, and goldfish. The T50% for aldolase from the hybrid embryos and fry was 1-4 degrees higher than for aldolase from the loach. The increase in T50% in the loach times danio and loach times rasbora hybrids was shown to be caused by functioning of the paternal aldolase-controlling genes, which began at the somite-formation stage and coincided with the increase in enzyme activity in the embryo. The value of T50% was increased to a greater extent and reached its maximum more rapidly in the somite tissues than in the cephalic tissues. A decrease in aldolase thermostability occurred in reciprocal danio times loach hybrids during the same developmental stages.

Animals↗

The effect of beta-bromopyruvic acid on fructose-1, 6-diphosphate aldolase from rabbit muscle.

Rabbit muscle aldolase (RMA) is 96 per cent inhibited in the presence of beta-bromopyruvic acid (BPA) in a molar ratio of 1/250, during 60 minutes incubation. The chemical reaction of higher significance in this phenomenon is the alkylation of -SHgroups of both apparent and buried types, with formation of S-pyruvil-cystein. The previous treatment of the enzyme with FDP protects aldolase, decreasing the rate of inhinition by BPA to about 56 per cent. FDP protection of the enzyme protects nearly 5-SH groups against the alkylating effect of BPA. Cyanogen bromide hydrolysis of the carboxymethylated protein results in the classical formation of 4 fragments, peptides F1, the NH-2terminal; F2, the COOH-terminal; F3, the active site containing peptide; and F4, a small peptide located between F2 F3. The protection bestowed upon the enzyme by FDP, against the alkylating effect of BPA, is located in the F1, F2, and F3 either in BPA treated aldolases or in the BPA treated FDP-aldolase. Part of the inhibiting effect of BPA is then attributed to the possible interaction between this compound and the basic aminoacids in the aldolase molecule.

Animals↗

[Elevation of serum creatine kinase and low serum aldolase in the patients with KANEMI YUSHOU].

We studied the rates of the patient with the elevation of serum creatine kinase using the routine medical checkup data from KANEMI YUSHOU patients between 1995 and 2001. We also studied the serum aldolase level and light microscopic observation of muscle tissue in rats during strenuous exercise given the polychlolinated biphenyls. Fifteen percent of the patients showed the elevation of serum creatine kinase. The patients with the elevation of serum creatine kinase also showed a higher concentration of polychlolinated biphenyls in their blood. 47.7% of the patients show low aldolase. There is no interrelation between the aldolase levels and PCBs or PCQs. There is also no interrelation between the serum levels of aldolase and creatine kinase. The rats given polycholorinated biphenyls showed a slight increase of necrotic fibers during strenuous exercise. Polycholorinated biphenyls may play some role for muscle necrosis. We could not clarify the significance of low serum aldolase in KANEMI YUSHOU.

Aged↗